EDWARDS LIFESCIENCES CORP (EWL.DE) Stock Fundamental Analysis
FRA:EWL • US28176E1082
69.85 EUR
+2.8 (+4.18%)
Last: Feb 24, 2026, 07:00 PM
EWL gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 65 industry peers in the Health Care Equipment & Supplies industry. EWL has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. EWL is quite expensive at the moment. It does show a decent growth rate. These ratings could make EWL a good candidate for quality investing.
1. Profitability
1.1 Basic Checks
- EWL had positive earnings in the past year.
- In the past year EWL had a positive cash flow from operations.
- Each year in the past 5 years EWL has been profitable.
- EWL had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
- EWL's Return On Assets of 10.31% is amongst the best of the industry. EWL outperforms 90.77% of its industry peers.
- Looking at the Return On Equity, with a value of 13.40%, EWL is in the better half of the industry, outperforming 78.46% of the companies in the same industry.
- EWL has a Return On Invested Capital of 12.09%. This is amongst the best in the industry. EWL outperforms 87.69% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.31% | ||
| ROE | 13.4% | ||
| ROIC | 12.09% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- With an excellent Profit Margin value of 23.25%, EWL belongs to the best of the industry, outperforming 93.85% of the companies in the same industry.
- EWL's Profit Margin has been stable in the last couple of years.
- The Operating Margin of EWL (27.73%) is better than 96.92% of its industry peers.
- In the last couple of years the Operating Margin of EWL has declined.
- With an excellent Gross Margin value of 78.19%, EWL belongs to the best of the industry, outperforming 92.31% of the companies in the same industry.
- In the last couple of years the Gross Margin of EWL has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 27.73% | ||
| PM (TTM) | 23.25% | ||
| GM | 78.19% |
OM growth 3Y-8.34%
OM growth 5Y-1.77%
PM growth 3Y-19.64%
PM growth 5Y-1.18%
GM growth 3Y-2.35%
GM growth 5Y0.69%
2. Health
2.1 Basic Checks
- EWL has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
- There is no outstanding debt for EWL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- An Altman-Z score of 12.01 indicates that EWL is not in any danger for bankruptcy at the moment.
- EWL has a Altman-Z score of 12.01. This is amongst the best in the industry. EWL outperforms 93.85% of its industry peers.
- EWL has a debt to FCF ratio of 0.75. This is a very positive value and a sign of high solvency as it would only need 0.75 years to pay back of all of its debts.
- Looking at the Debt to FCF ratio, with a value of 0.75, EWL belongs to the top of the industry, outperforming 90.77% of the companies in the same industry.
- EWL has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.
- The Debt to Equity ratio of EWL (0.06) is better than 84.62% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.06 | ||
| Debt/FCF | 0.75 | ||
| Altman-Z | 12.01 |
ROIC/WACC1.23
WACC9.84%
2.3 Liquidity
- A Current Ratio of 4.00 indicates that EWL has no problem at all paying its short term obligations.
- With an excellent Current ratio value of 4.00, EWL belongs to the best of the industry, outperforming 92.31% of the companies in the same industry.
- EWL has a Quick Ratio of 3.29. This indicates that EWL is financially healthy and has no problem in meeting its short term obligations.
- The Quick ratio of EWL (3.29) is better than 92.31% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4 | ||
| Quick Ratio | 3.29 |
3. Growth
3.1 Past
- The earnings per share for EWL have decreased by -2.29% in the last year.
- Measured over the past 5 years, EWL shows a small growth in Earnings Per Share. The EPS has been growing by 6.67% on average per year.
- The Revenue has grown by 10.86% in the past year. This is quite good.
- The Revenue has been growing slightly by 6.70% on average over the past years.
EPS 1Y (TTM)-2.29%
EPS 3Y1.06%
EPS 5Y6.67%
EPS Q2Q%-1.69%
Revenue 1Y (TTM)10.86%
Revenue growth 3Y10.77%
Revenue growth 5Y6.7%
Sales Q2Q%13.26%
3.2 Future
- Based on estimates for the next years, EWL will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.79% on average per year.
- The Revenue is expected to grow by 9.72% on average over the next years. This is quite good.
EPS Next Y16.14%
EPS Next 2Y13.34%
EPS Next 3Y13.01%
EPS Next 5Y12.79%
Revenue Next Year10.47%
Revenue Next 2Y10.14%
Revenue Next 3Y10.12%
Revenue Next 5Y9.72%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 32.19, EWL can be considered very expensive at the moment.
- The rest of the industry has a similar Price/Earnings ratio as EWL.
- EWL is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 26.98, which is the current average of the S&P500 Index.
- The Price/Forward Earnings ratio is 27.69, which means the current valuation is very expensive for EWL.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of EWL indicates a slightly more expensive valuation: EWL is more expensive than 60.00% of the companies listed in the same industry.
- The average S&P500 Price/Forward Earnings ratio is at 28.01. EWL is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.19 | ||
| Fwd PE | 27.69 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, EWL is valued a bit more expensive than the industry average as 63.08% of the companies are valued more cheaply.
- EWL's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 59.74 | ||
| EV/EBITDA | 23.94 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
- EWL has a very decent profitability rating, which may justify a higher PE ratio.
- A more expensive valuation may be justified as EWL's earnings are expected to grow with 13.01% in the coming years.
PEG (NY)1.99
PEG (5Y)4.82
EPS Next 2Y13.34%
EPS Next 3Y13.01%
5. Dividend
5.1 Amount
- EWL does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
FRA:EWL (2/24/2026, 7:00:00 PM)
69.85
+2.8 (+4.18%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-10 2026-02-10/amc
Earnings (Next)04-21 2026-04-21/amc
Inst Owners89.94%
Inst Owner ChangeN/A
Ins Owners0.11%
Ins Owner ChangeN/A
Market Cap40.53B
Revenue(TTM)6.07B
Net Income(TTM)1.37B
Analysts79.53
Price Target82.86 (18.63%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.01%
Min EPS beat(2)4.4%
Max EPS beat(2)9.63%
EPS beat(4)4
Avg EPS beat(4)5.38%
Min EPS beat(4)3.4%
Max EPS beat(4)9.63%
EPS beat(8)5
Avg EPS beat(8)2.27%
EPS beat(12)6
Avg EPS beat(12)1.21%
EPS beat(16)7
Avg EPS beat(16)-0.18%
Revenue beat(2)1
Avg Revenue beat(2)0.37%
Min Revenue beat(2)-0.12%
Max Revenue beat(2)0.85%
Revenue beat(4)1
Avg Revenue beat(4)-0.56%
Min Revenue beat(4)-2.1%
Max Revenue beat(4)0.85%
Revenue beat(8)1
Avg Revenue beat(8)-2.7%
Revenue beat(12)2
Avg Revenue beat(12)-2.12%
Revenue beat(16)2
Avg Revenue beat(16)-2.48%
PT rev (1m)-2.06%
PT rev (3m)1.9%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.06%
EPS NY rev (1m)0.43%
EPS NY rev (3m)1.63%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.38%
Revenue NY rev (1m)0.67%
Revenue NY rev (3m)0.9%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.19 | ||
| Fwd PE | 27.69 | ||
| P/S | 8.12 | ||
| P/FCF | 59.74 | ||
| P/OCF | 46.98 | ||
| P/B | 4.68 | ||
| P/tB | 6.54 | ||
| EV/EBITDA | 23.94 |
EPS(TTM)2.17
EY3.11%
EPS(NY)2.52
Fwd EY3.61%
FCF(TTM)1.17
FCFY1.67%
OCF(TTM)1.49
OCFY2.13%
SpS8.6
BVpS14.92
TBVpS10.68
PEG (NY)1.99
PEG (5Y)4.82
Graham Number26.99
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.31% | ||
| ROE | 13.4% | ||
| ROCE | 13.97% | ||
| ROIC | 12.09% | ||
| ROICexc | 18.01% | ||
| ROICexgc | 28.58% | ||
| OM | 27.73% | ||
| PM (TTM) | 23.25% | ||
| GM | 78.19% | ||
| FCFM | 13.59% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-8.34%
OM growth 5Y-1.77%
PM growth 3Y-19.64%
PM growth 5Y-1.18%
GM growth 3Y-2.35%
GM growth 5Y0.69%
F-Score5
Asset Turnover0.44
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.06 | ||
| Debt/FCF | 0.75 | ||
| Debt/EBITDA | 0.33 | ||
| Cap/Depr | 138.79% | ||
| Cap/Sales | 3.69% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 56.86% | ||
| Profit Quality | 58.45% | ||
| Current Ratio | 4 | ||
| Quick Ratio | 3.29 | ||
| Altman-Z | 12.01 |
F-Score5
WACC9.84%
ROIC/WACC1.23
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2.29%
EPS 3Y1.06%
EPS 5Y6.67%
EPS Q2Q%-1.69%
EPS Next Y16.14%
EPS Next 2Y13.34%
EPS Next 3Y13.01%
EPS Next 5Y12.79%
Revenue 1Y (TTM)10.86%
Revenue growth 3Y10.77%
Revenue growth 5Y6.7%
Sales Q2Q%13.26%
Revenue Next Year10.47%
Revenue Next 2Y10.14%
Revenue Next 3Y10.12%
Revenue Next 5Y9.72%
EBIT growth 1Y4.68%
EBIT growth 3Y1.54%
EBIT growth 5Y4.82%
EBIT Next Year24.3%
EBIT Next 3Y14.62%
EBIT Next 5Y14.72%
FCF growth 1Y67.7%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y26.09%
OCF growth 3YN/A
OCF growth 5YN/A
EDWARDS LIFESCIENCES CORP / EWL.DE FAQ
Can you provide the ChartMill fundamental rating for EDWARDS LIFESCIENCES CORP?
ChartMill assigns a fundamental rating of 6 / 10 to EWL.DE.
What is the valuation status of EDWARDS LIFESCIENCES CORP (EWL.DE) stock?
ChartMill assigns a valuation rating of 2 / 10 to EDWARDS LIFESCIENCES CORP (EWL.DE). This can be considered as Overvalued.
What is the profitability of EWL stock?
EDWARDS LIFESCIENCES CORP (EWL.DE) has a profitability rating of 7 / 10.
What are the PE and PB ratios of EDWARDS LIFESCIENCES CORP (EWL.DE) stock?
The Price/Earnings (PE) ratio for EDWARDS LIFESCIENCES CORP (EWL.DE) is 32.19 and the Price/Book (PB) ratio is 4.68.